These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1963692)

  • 1. Subclasses of platelet 3H-imipramine binding sites.
    DeMet EM; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):293-302. PubMed ID: 1963692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.
    DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.
    DeMet EM; Chicz-DeMet A; Bell KM; Reist C; Gerner RH
    Psychiatry Res; 1990 Dec; 34(3):303-13. PubMed ID: 1963693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
    Severson JA; Schneider LS; Fredrickson ER
    Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
    Galzin AM; Lôo H; Sechter D; Langer SZ
    Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors.
    Tang SW; Cheung S; Strijewski A; Chudzik J; Helmeste D
    Psychiatry Res; 1990 Nov; 34(2):205-12. PubMed ID: 1962863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine binding sites in brain and platelets: role in affective disorders.
    Hrdina PD
    Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.